Rifampin as adjuvant treatment of Gram-positive bacterial infections: A systematic review of comparative clinical trials

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 26, Issue 12, 2007, Pages 849-856

  Bliziotis, I A ^a   Ntziora, F ^a   Lawrence, K R ^b,c   Falagas, M E ^a,c,d  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b TUFTS MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HENRY DUNANT HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; CEFALOTIN; CEFAPIRIN; CEFTRIAXONE; CIPROFLOXACIN; ERYTHROMYCIN; FLUCLOXACILLIN; NAFCILLIN; OXACILLIN; PENICILLIN V; PENICILLIN V POTASSIUM; RIFAMPICIN; VANCOMYCIN;

ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; BILIRUBIN BLOOD LEVEL; CLINICAL TRIAL; DATA ANALYSIS; DIARRHEA; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG WITHDRAWAL; EOSINOPHILIA; GRAM POSITIVE BACTERIUM; HUMAN; INJECTION SITE PAIN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; UREMIA; URTICARIA; VOMITING;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; RIFAMPIN;

EID: 36049003404     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-007-0378-1     Document Type: Review

References (30)

1. Calderon E, Gatica R, Echaniz G et al (1991) Treatment of presumed bacterial pneumonia in ambulatory children. Clin Ther 13(6):699-706
2. Falagas ME, Fragoulis KN, Bliziotis IA (2006) Oral rifampin for prevention of S. aureus carriage-related infections in patients with renal failure-a meta-analysis of randomized controlled trials. Nephrol Dial Transplant 21(9):2536-2542
3. Kissling M, Bergamini N (1981) Rifampicin in free combination with other antimicrobial drugs in non-Tb infections. Clinical data on 650 patients (a review). Chemotherapy 27(5):368-402
4. Korvick JA, Peacock JE Jr, Muder RR, Wheeler RR, Yu VL (1992) Addition of rifampin to combination antibiotic therapy for Pseudomonas aeruginosa bacteremia: prospective trial using the Zelen protocol. Antimicrob Agents Chemother 36(3):620-625
5. Muder RR, Boldin M, Brennen C et al (1994) A controlled trial of rifampicin, minocycline, and rifampicin plus minocycline for eradication of methicillin-resistant Staphylococcus aureus in long-term care patients. J Antimicrob Chemother 34(1):189-190
6. Tanz RR, Shulman ST, Barthel MJ, Willert C, Yogev R (1985) Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr 106(6):876-880
7. Baddour LM, Wilson WR, Bayer AS et al (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American heart association: endorsed by the infectious diseases society of America. Circulation 111:394-434
8. Elliott TS, Foweraker J, Gould FK, Perry JD, Sandoe JA (2004) Working party of the British society for antimicrobial chemotherapy. Guidelines for the antibiotic treatment of endocarditis in adults: report of the working party of the British society for antimicrobial chemotherapy. J Antimicrob Chemother 54:971-981
9. Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, Warren RE; The Joint Working Party of the British Society of Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurse Association (2006) Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 57:589-608
10. Archer GL, Tenenbaum MJ, Haywood HB 3rd (1978) Rifampin therapy of Staphylococcus epidermidis. Use in infections from indwelling artificial devices. JAMA 240(8):751-753
11. Archer GL, Johnston JL, Vazquez GJ, Haywood HB 3rd (1983) Efficacy of antibiotic combinations including rifampin against methicillin-resistant Staphylococcus epidermidis: in vitro and in vivo studies. Rev Infect Dis 5(Suppl 3):S538-S542
12. Faville RJ Jr, Zaske DE, Kaplan EL, Crossley K, Sabath LD, Quie PG (1978) Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. JAMA 240(18):1963-1965
13. Hedberg A, Hardemark HG, Olsson-Liljequist B, Sjolin J (2004) Penetration of fusidic acid and rifampicin into cerebrospinal fluid in low-grade inflammatory meningitis caused by Staphylococcus epidermidis. Clin Microbiol Infect 10(8):765-768
14. Chaudhary S, Bilinsky SA, Hennessy JL et al (1985) Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy. J Pediatr 106:481-486
15. Klugman KP, Friedland IR, Bradley JS (1995) Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 39:1988-1992
16. Levine DP, Fromm BS, Reddy BR (1991) Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 115:674-680
17. Norden CW, Bryant R, Palmer D, Montgomerie JZ, Wheat J (1986) Chronic osteomyelitis caused by Staphylococcus aureus: controlled clinical trial of nafcillin therapy and nafcillin-rifampin therapy. South Med J 79:947-951
18. Van der Auwera P, Klastersky J, Thys JP, Meunier-Carpentier F, Legrand JC (1985) Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections. Antimicrob Agents Chemother 28:467-472
19. Van der Auwera P, Meunier-Carpentier F, Klastersky J (1983) Clinical study of combination therapy with oxacillin and rifampin for staphylococcal infections. Rev Infect Dis 5(Suppl 3):515-522
20. Vincent F, Ross JB, Dalton M, Wort AJ (1992) A therapeutic trial of the use of penicillin V or erythromycin with or without rifampin in the treatment of psoriasis. J Am Acad Dermatol 26:458-461
21. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE; The Foreign-body infection (FBI) Study Group (1998) Role of rifampin for treatment of orthopaedic implant-related Staphylococcal infections; A randomized controlled trial. JAMA 279:1537-1541
22. Karchmer AW, Archer GL, Dismukes WE (1983) Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis. Rev Infect Dis 5(Suppl 3):S543-S548
23. Konig DP, Schierholz JM, Munnich U, Rutt J (2001) Treatment of staphylococcal implant infection with rifampicin-ciprofloxacin in stable implants. Arch Orthop Trauma Surg 121(5):297-299
24. Swanberg L, Tuazon CU (1984) Rifampin in the treatment of serious staphylococcal infections. Am J Med Sci 287(3):49-54
25. Consterton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: A common cause of persistent infections. Science 284:1318-1322
26. Peck KR, Kim SW, Jung SI et al (2003) Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis. Chemotherapy 49(4):189-193
27. Saginur R, St Denis M, Ferris W et al (2006) Multiple combination bactericidal testing of Staphylcoccal biofilms from implant-associated infections. Antimicrob Agents Chemother 50:55-61
28. Zheng Z, Stewart PS (2002) Penetration of rifampin through Staphylcoccus epidermidis biofilms. Antimicrob Agents Chemother 46:900-903
29. Falagas ME, Matthaiou DK, Bliziotis IA (2006) The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. J Antimicrob Chemother 57(4):639-647
30. Bayer AS, Lam K (1985) Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. J Infect Dis 151:157-165